VanEck Pharmaceutical ETF PPH
119.03 USD -3.06 (-2.51%)
At closeNov 6, 2026, 5:19 AM EST
118.00 -1.03 -0.87%
Pre-market · Nov 6, 5:19 AM ET
118.91 Day range 123.50
93.11 52-week range 123.50
- YTD
- +15.37%
- 1 year
- +26.22%
- Market cap
- 1.14B
- EPS (ttm)
- 4.29
- P/E ratio
- 27.78
- YTD return
- +15.37%
- 1-year return
- +26.22%
- Volume
- 309.47K
- Avg volume
- 315.99K
- Open
- 122.74
- Previous close
- 122.09
- Day's range
- 118.91 – 123.50
- 52-week range
- 93.11 – 123.50
MAX +78.81 (+195.95%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 112.68
- 200-day average
- 108.05
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.